ClinicalTrials.Veeva

Menu

Role of Nutritional Support in Idiopathic Male Infertility

N

NATURAmedicatrix

Status

Unknown

Conditions

Infertility, Male

Treatments

Dietary Supplement: Dietary Supplement with L-carnitine (FertilHom)
Dietary Supplement: Control Dietary Supplement

Study type

Interventional

Funder types

Industry

Identifiers

NCT03588949
NATURAmedicatrix-FE-0001-M

Details and patient eligibility

About

Approximately 100 males with idiopathic infertility and oligo- and/or astheno- and/or and/or teratozoospermia and fertile woman will take a Test dietary supplement (TDS), containing carnitine, vitamins and trace elements (active group) or carotene (control group) for 6 months (50 subjects in active and control groups). Before intake, and 2 and 4 months after the commencement of TDS, all males will have spermogram. After 6-month use of the TDS and during the 12th month of the study, couples will be screened for conception, pregnancy, and a newborn

Enrollment

100 estimated patients

Sex

Male

Ages

21 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Informed consent form signed;
  2. Age: 21-50;
  3. Idiopathic male infertility;
  4. Idiopathic oligo- and/or astheno- and/or teratozoospermia;
  5. Stated availability throughout the study period and a mobile phone

Exclusion criteria

  1. Allergy to any component of the dietary supplement;
  2. Known genetic, anatomical, endocrine, inflammatory or traumatic testicular cause of male infertility;
  3. Known genetic, anatomical, endocrine, inflammatory or traumatic testicular cause of female infertility;
  4. Inflammatory bowel disease;
  5. Known moderate to severe disease of any systems;
  6. Known or suspected sexually transmitted diseases;
  7. Alcohol or drug addiction of any couple counterpart as suspected by investigator;
  8. Difficulty to comprehend study requirements as judged by investigator;
  9. Use of any investigational product within the previous 3 months before entering the study;
  10. Use of any drugs that stimulate or suppress spermatogenesis within previous 3 months

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups, including a placebo group

Active Dietary Supplement
Experimental group
Description:
Dietary Supplement with L-carnitine (FertilHom)
Treatment:
Dietary Supplement: Dietary Supplement with L-carnitine (FertilHom)
Control Dietary Supplement
Placebo Comparator group
Description:
Dietary Supplement with 50% RDA of beta-carotene
Treatment:
Dietary Supplement: Control Dietary Supplement

Trial contacts and locations

1

Loading...

Central trial contact

Sergiy V Gerasymov, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems